Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents

Abstract

Type II DNA topoisomerases have the ability to generate a transient DNA double-strand break through which a second duplex can be passed; an activity essential for DNA decatenation and unknotting. Topoisomerase poisons stabilize the normally transient topoisomerase-induced DSBs and are potent and widely used anticancer drugs. However, their use is associated with therapy-related secondary leukemia, often bearing 11q23 translocations involving the MLL gene. We will explain recent discoveries in the fields of topoisomerase biology and transcription that have consequences for our understanding of the etiology of leukemia, especially therapy-related secondary leukemia and describe how these findings may help minimize the occurrence of these neoplasias.

DOI: 10.3390/ijerph9062075

Extracted Key Phrases

8 Figures and Tables

010020030020132014201520162017
Citations per Year

469 Citations

Semantic Scholar estimates that this publication has 469 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Cowell2012MechanismOG, title={Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents}, author={Ian G. Cowell and Caroline Ann Austin}, booktitle={International journal of environmental research and public health}, year={2012} }